Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Cellebrite DI (CLBT) EBT Margin (2020 - 2025)

Historic EBT Margin for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to 20.39%.

  • Cellebrite DI's EBT Margin rose 21500.0% to 20.39% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.06%, marking a year-over-year increase of 878500.0%. This contributed to the annual value of 19.06% for FY2025, which is 878500.0% up from last year.
  • Latest data reveals that Cellebrite DI reported EBT Margin of 20.39% as of Q4 2025, which was up 21500.0% from 19.27% recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's EBT Margin ranged from a high of 79.69% in Q4 2021 and a low of 191.41% during Q3 2024
  • Its 5-year average for EBT Margin is 3.55%, with a median of 13.51% in 2021.
  • Per our database at Business Quant, Cellebrite DI's EBT Margin tumbled by -1995500bps in 2024 and then surged by 2106800bps in 2025.
  • Cellebrite DI's EBT Margin (Quarter) stood at 79.69% in 2021, then tumbled by -85bps to 12.3% in 2022, then plummeted by -208bps to 13.27% in 2023, then skyrocketed by 237bps to 18.25% in 2024, then rose by 12bps to 20.39% in 2025.
  • Its EBT Margin was 20.39% in Q4 2025, compared to 19.27% in Q3 2025 and 18.35% in Q2 2025.